Advertisements

Ретинол

Quick links to important sections

Ретинол

Advertisements

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Ретинол

What is Retinol (Vitamin A)?

Property Description
Active Ingredient Retinol (Vitamin A), typically as Acetate or Palmitate esters
Form Oil Solution, Capsules, Creams, Lotions
Pharmacological Class Fat-Soluble Vitamin, Retinoid
Common Use Prevention/Correction of Vitamin A Deficiency
Origin Natural or Synthetic

Retinol is the official INN (International Nonproprietary Name) for Vitamin A, an essential fat-soluble vitamin and the fundamental compound in the retinoid group. It is classified primarily as a vitamin preparation (ATC code A11CA01), but its role in skin health also places it under dermatological agents. The active ingredients in most Retinol products are stabilized esters, such as Retinol acetate or Retinol palmitate, which the body converts into the active metabolite, retinoic acid. Unlike more potent, prescription-only synthetic retinoids, Retinol itself is widely recognized as an accessible, often over-the-counter (OTC) component.

Form, Composition, and Purpose

Retinol is available in diverse dosage forms, notably oil solutions and capsules for oral intake, as well as medical creams and lotions for topical administration. This dual administration route allows it to address systemic deficiency and local skin concerns. The overarching general purpose of Retinol is the prevention and reversal of Vitamin A deficiency or Hypovitaminosis A, a condition clinically recognized for causing night blindness and impaired immune response.

Its recognized actions include maintaining epithelial integrity and a crucial contribution to the visual cycle. Vitamin A is essential for normal vision, immune function, and the maintenance of organs such as the heart and lungs. Its function as a foundational nutrient differentiates it from newer retinoids focused solely on specific skin conditions.

Advertisements

What side effects are possible with Ретинол?

Possible Side Effects and Safety Information

The official safety profile for Retinol (Vitamin A), particularly concerning systemic use, is structured around the recognized potential for Hypervitaminosis A (toxicity) resulting from chronic or excessive intake, as documented by regulatory bodies.


Adverse Reaction Scope and Classification

Adverse effects are categorized by frequency and system-organ class. Common reactions listed in regulatory documents include headache, fatigue, nausea, vomiting, abdominal pain, and skin and subcutaneous tissue disorders such as dry skin and hair loss (alopecia). Effects are documented across the Nervous System, Gastrointestinal System, and Integumentary System.


Serious Adverse Reactions and Restrictions

Systemic use is associated with several serious adverse reactions. Officially listed concerns include Teratogenicity (a severe risk of fetal malformation), Hepatotoxicity (severe liver impairment), and Intracranial Hypertension (Pseudotumor Cerebri), which involves increased pressure around the brain.

Most severe reactions are explicitly linked to chronic overexposure or high cumulative doses. Consequently, the use of high systemic doses is absolutely contraindicated during pregnancy and in patients with established Hypervitaminosis A.


Safety Profile Context

The regulatory framework highlights the severe, potentially irreversible risks of organ toxicity and fetal harm associated with chronic, high systemic doses. Many of the less severe symptoms of toxicity, such as dry skin and fatigue, are documented as reversible upon discontinuation of the excessive intake.

Advertisements

Overdose and Emergency Response

Overdose of Retinol (Vitamin A) results in a toxic state known as Hypervitaminosis A, which is officially characterized into two forms: acute and chronic toxicity. Acute toxicity, resulting from a single, high-dose ingestion, often presents with severe manifestations such as headache, nausea, vomiting, dizziness, and skin desquamation. Chronic toxicity, resulting from prolonged excessive intake, is marked by systemic symptoms including dry/coarse skin, alopecia (hair loss), arthralgia (joint pain), and potential hepatotoxicity.


Severe outcomes documented in regulatory sources include potentially life-threatening conditions like Increased Intracranial Pressure (Pseudotumor Cerebri), and, in prolonged chronic cases, hepatic fibrosis or cirrhosis. Due to these risks, immediate medical attention must be sought if severe symptoms, such as an unrelenting headache, uncontrolled vomiting, or altered consciousness, are suspected.


The mandated procedure for overdose is the immediate withdrawal of all Vitamin A intake, as no specific antidote is known. Management is primarily symptomatic and supportive. Furthermore, high doses of Retinol are contraindicated during pregnancy due to the critical risk of fetal teratogenicity. Infants are noted to be highly sensitive to smaller toxic doses, potentially presenting with bulging fontanelles.

Advertisements

Therapeutic Uses of Ретинол

Retinol (Vitamin A) is generally considered relevant across distinct medical domains, primarily targeting symptoms related to systemic nutritional imbalance and localized skin concerns. Its function involves supporting these physiological areas.

This supportive compound is commonly used for managing the manifestations of Vitamin A Deficiency (Hypovitaminosis A), which are conditions involving episodic or fluctuating manifestations. It is applied in addressing symptoms related to organ-specific functional stress (the eye), such as night blindness (Nyctalopia). In dermatological settings, it is applied across domains where additional symptomatic support is needed to address signs of chronic sun damage (photoaging), fine lines, and Acne vulgaris.

“The symptomatic relief provided by Retinol helps ease the overall burden of symptoms associated with deficiency and contributes to improved comfort during periods of heightened symptoms.”

Essential Support Domains

Retinol is commonly used to help with the symptoms associated with Vitamin A deficiency, such as Nyctalopia and Xerophthalmia, and is relevant for easing symptoms related to photoaging and mild to moderate acne. This application may assist with maintaining functional stability and supports general well-being during symptomatic phases.


Quick Fact: Relief for Visual Impairment Retinol may be part of symptomatic management in clinical settings that involve symptoms that interfere with daily functioning related to vision, providing supportive relief that helps patients cope more steadily with visual symptoms, such as poor adaptation to darkness.

Advertisements

Eligibility and Restrictions for Use

Official Eligibility and Contraindications for Retinoids

Eligibility for retinoid products, including prescription forms like Tretinoin and Isotretinoin, is strictly governed by governmental regulatory standards (e.g., FDA, EMA) to mitigate known risks, primarily teratogenicity (severe birth defects).

Population Eligibility Status Regulatory Requirement
Absolute Contraindication Pregnant women and individuals with a known hypersensitivity to the drug or its components.
Strictly Prohibited Women who may become pregnant unless fully enrolled and compliant with a mandatory Pregnancy Prevention Programme (for oral forms).
Conditional Use Women of childbearing potential must use two effective forms of contraception and undergo regular monitoring.
Not Established Use Pediatric patients below the age threshold specified on the label (typically 9 or 12 years), as safety and efficacy data are lacking.
Condition Restriction Use is contraindicated on sunburned or eczematous skin. Patients must avoid excessive sun exposure during treatment.

Use during breastfeeding is generally not recommended, as it is unknown if the medication is excreted into human milk. This structure ensures that only individuals who meet specific physiological and risk-management criteria are eligible for treatment.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Retinol (Vitamin A) focuses on managing additive toxicity risk and potential interference with absorption, as described in official government regulatory documents. Co-administration of certain substances is strictly constrained.

Interaction Type Interacting Substances/Class Official Regulatory Statement
Additive Toxicity Other Retinoids, Vitamin A Supplements Combination is prohibited due to the severe risk of Hypervitaminosis A.
Combined Risk Tetracycline-class Antibiotics Co-administration is formally restricted due to the combined risk of Benign Intracranial Hypertension.
Exposure Reduction Mineral Oil, Bile Acid Sequestrants (Cholestyramine) Requires mandatory separation of doses to mitigate reduced Retinol absorption and systemic exposure.

High doses of Retinol may lead to the potentiation of effects from Vitamin K antagonists, which is documented as a pharmacodynamic interaction. Additionally, Oral Contraceptives containing Estrogen may increase Retinol plasma concentrations. Chronic, excessive alcohol consumption is noted to potentially deplete the body's hepatic Vitamin A stores, altering the overall systemic status. The interaction risk, particularly relating to toxicity, may be heightened in patients with underlying hepatic impairment. The profile emphasizes pharmacodynamic and absorption-related risks over metabolic interference.

Advertisements

Mechanism of Action

Retinol, a derivative of Vitamin A, is first converted into its active metabolite, Retinoic Acid (RA). This RA functions as a ligand for intracellular Retinoic Acid Receptors (RARs) and Retinoid X Receptors (RXRs). The ligand-receptor complex translocates to the cell nucleus where it acts as a transcription factor, binding to Retinoic Acid Response Elements (RAREs) on specific DNA sequences. This process mediates the activation or suppression of target genes, resulting in altered protein synthesis and downstream cellular effects.

This core transcriptional mechanism controls two major physiological cascades. First, it modulates the expression of genes governing the cellular life cycle, specifically influencing the rate of keratinocyte proliferation and the organization of terminal differentiation, leading to altered epidermal architecture. Second, it affects the extracellular matrix (ECM) by mediating the reduction of Matrix Metalloproteinase (MMP) transcription and facilitating enhanced production of ECM components like collagen, thereby modulating dermal structural composition.

Advertisements

Dosage and Administration Information

The administration of Retinol (Vitamin A) for therapeutic deficiency is determined by the severity of the condition and the patient’s ability to absorb the compound. There are two primary administration routes. For prophylaxis or long-term follow-up therapy, the oral route (PO) is used, typically with dosages ranging from 10,000 IU to 20,000 IU once daily. Conversely, the intramuscular route (IM) is reserved for the initial, intensive correction of severe deficiency or in cases where oral absorption is compromised by conditions such as malabsorption syndrome. The injectable solution is for intramuscular use only and requires supervision by a healthcare professional.

The therapeutic course is structured into distinct phases with specific dosing. Initial intensive IM therapy uses a high dose of 100,000 IU daily for three days, followed by an intermediate phase of 50,000 IU IM daily for two weeks. This is then followed by an oral follow-up regimen lasting up to two months. For oral administration, it is noted that the medicine must be taken with a fatty meal to ensure proper absorption of this fat-soluble compound.

Dosing is adjusted for specific patient populations. Pediatric patients (ages 1–8 years) and infants receive significantly reduced therapeutic doses, ranging from 7,500 IU to 35,000 IU daily, depending on age. For females who are pregnant or lactating, intake must align with the specified Recommended Dietary Allowance (RDA) of 770 mug RAE and 1,300 mug RAE, respectively.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Retinol

Evidence for Systemic Use in Deficiency and Vision

Research has been conducted to evaluate the role of Retinol (Vitamin A) in conditions related to nutritional deficiency (Hypovitaminosis A). Studies have focused on systemic administration, primarily involving large-scale Randomized Controlled Trials (RCTs) and comprehensive meta-analyses conducted in various populations globally. Researchers have explored outcomes related to systemic or functional imbalance, including the monitoring of deficiency-related illness and the function of the visual system. Studies conducted during periods of increased symptom activity have closely monitored clinical signs. These trials examined changes in nutritional biomarkers, specifically measured serum retinol concentrations, following Vitamin A supplementation. Research describes patterns observed in the evaluation of symptoms like night blindness (Nyctalopia) and other conditions where symptoms may vary in intensity.

Evidence for Localized Use in Dermatological Concerns

Randomized Controlled Trials (RCTs) have primarily examined the use of topical Retinol for localized skin issues, over intermediate follow-up durations (typically several months). These studies were observed in adult populations and focused on mild to moderate acne and the signs of chronic sun damage (photoaging), including the measurement of fine lines and changes in skin texture. Studies monitored changes in clinical assessment scores for the appearance of fine lines and assessments of overall skin texture, measured during the study period. For acne, trials explored how symptom intensity or variability was evaluated by counting inflammatory and non-inflammatory lesions. The findings describe patterns observed in these studies, related to measurements of both the visual appearance of photoaged skin and the severity of mild to moderate acne.

Research Gaps and Areas of Uncertainty

The overall research landscape contains several gaps regarding Retinol’s specific application as a non-prescription treatment. Evidence quality varies across studies, particularly for cosmetic or mild dermatological claims, where results apply only to the populations studied and specific formulations. Comparative evidence is lacking in several domains, making comprehensive comparison uncertain against other active ingredients that address similar skin concerns. As noted, data describing long-term effects are not fully established for topical application, and research provides context but not individual predictions regarding extended use. This evidence highlights what is known — and what is still uncertain — about Retinol.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Ретинол (FAQ)


Q: How quickly does Ретинол start working?

Studies examining the effects of Retinol for localized skin concerns typically involve intermediate follow-up periods, often lasting several months. Official product information for some related treatments indicates that initial improvements may be noted after two weeks. However, sustained observations or noticeable benefits are typically reported after seven weeks or more of continuous use, according to research findings.


Q: Can Ретинол be used by teenagers?

Regulatory documents for certain topical retinoid products indicate approval for use in patients who are 12 years of age and older. For individuals younger than the specified age threshold, the use of these regulated products is generally associated with the oversight of a healthcare professional, as safety data may be limited.


Q: Is Ретинол safe to use if I am trying to get pregnant?

According to official regulatory guidance, the use of Retinol and related retinoid products is strictly prohibited for women who are pregnant or who may become pregnant. Official regulatory documents indicate that individuals who are attempting to conceive have been advised to discontinue use for a specified period as a precaution, due to the risk of fetal harm.


Q: Can Ретинол be used around the eyes?

Official instructions for the application of some regulated topical retinoid products advise users to avoid contact with sensitive areas. This guidance indicates that users should avoid contact with the eyes and mucous membranes due to the risk of localized irritation.


Q: Can I use Ретинол if I have sensitive skin?

Regulatory documents recognize that the potential for local skin irritation is a documented adverse reaction when using retinoids. Therefore, use is specifically contraindicated on skin conditions like eczema or where the skin is already sunburned. The documented potential for local skin irritation suggests that those with sensitive skin may experience irritation, which is a common adverse reaction.


Q: Can I use Ретинол if I have eczema?

Official eligibility criteria for topical retinoids explicitly state that the product is contraindicated for use on eczematous skin (skin affected by eczema). Use is also contraindicated on skin that is sunburned. This contraindication is applied where the skin is compromised, consistent with regulatory guidelines for preventing adverse skin reactions.


Q: What kind of research has been done on Ретинол?

The research evidence for Retinol is primarily based on Randomized Controlled Trials (RCTs) and comprehensive meta-analyses. These studies have examined its systemic use for nutritional deficiency and its localized use for dermatological issues, including mild to moderate acne and the signs of chronic sun damage (photoaging).


Q: Can men use Ретинол?

Official eligibility and restriction criteria for retinoids primarily focus on mandatory precautions for women of childbearing potential, such as the use of effective contraception. There are no specific regulatory restrictions or warnings concerning the use of Retinol by men.


Q: Does using Ретинол make acne worse before it gets better?

Official product labels for some regulated topical retinoids note that users may experience an initial worsening of inflammatory lesions during the early weeks of treatment. According to this guidance, if the product is tolerated, this temporary increase in symptoms is not described as a reason to discontinue use.


Q: Can I use Ретинол while breastfeeding?

Use of Retinol while breastfeeding is generally not recommended according to official safety guidelines. This is a cautionary stance taken because it is not definitively known whether the medication is excreted into human milk or what effects it may have on the infant.


Q: Can I use products containing salicylic acid while using Ретинол?

Regulatory documents for some related topical retinoids caution users to exercise particular care when combining them with other topical over-the-counter acne preparations. This cautionary note specifically includes ingredients such as salicylic acid, and is based on a risk of increased skin irritation.


Q: Are there any reported cases of severe allergic reactions to Ретинол?

Retinol is contraindicated for use in individuals who have a known hypersensitivity (severe allergic tendency) to the drug or any of its components. Reports of adverse events, including allergic reactions, are submitted to regulatory agencies (such as through MedWatch) for monitoring, as the product is contraindicated in individuals with a known hypersensitivity.


Q: How is the safety of Ретинол monitored after it is approved?

Drug safety is continuously monitored after approval by governing regulatory agencies, such as the FDA. This process involves reviewing submitted reports of adverse events from consumers and health professionals, known as pharmacovigilance. It also includes conducting inspections of manufacturing facilities and regulating promotional materials.


Q: Does Ретинол interact with any herbal supplements?

Official drug information sheets typically state that patients should discuss with their healthcare provider all products being used. This discussion should cover prescription and over-the-counter medicines, as well as vitamins, minerals, herbal products, and other supplements.


Q: How is the efficacy of Ретинол measured in clinical studies?

In clinical studies, the efficacy of Retinol is measured differently based on its use. For systemic (internal) use, researchers monitor serum retinol concentrations in the blood. For localized skin concerns, efficacy is typically measured using clinical assessment scores, which evaluate changes in the appearance of fine lines, overall skin texture, and by counting inflammatory and non-inflammatory lesions.

Advertisements

How should Ретинол be stored and disposed of?

How to Store and Dispose of Retinol

The official storage profile for Retinol is designed to protect it from degradation due to its sensitivity to light, heat, and air oxidation, as stated in regulatory documents.

Requirement Type Official Instructions
Storage Environment Store in a cool, dry place between 15 C and 30 C. Protect from light and do not freeze.
Packaging Rules Keep the product in its original, tightly closed, light-resistant container.
Safety & Handling Keep out of the reach of children. Keep away from heat, flame, and sources of ignition (particularly for gels).
Disposal Instructions Do not dispose of in household trash or pour down sinks/drains. Use a drug take-back program or follow official local regulations for proper discard to avoid environmental release.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ретинол found in:

A-Z Index: